Ayala Pharmaceuticals, Inc. ADXS
0.60 USD 0.00 (+0.00%)
At closeFeb 4, 2026, 4:00 PM EST
0.0846 Day range 0.60355
0.121 52-week range 1.57
- YTD
- +1,405.11%
- 1 year
- +2,014.01%
News
defenseworld.net Aadi Bioscience (NASDAQ:AADI) and Ayala Pharmaceuticals (NASDAQ:ADXS) Head to Head Analysis Insider and Institutional Ownership 7.2% of Ayala Pharmaceuticals shares are owned by institutional investors. Comparatively, 52.1% of Aadi Bioscience shares are owned by institutional investors.…
defenseworld.net Head-To-Head Survey: Evofem Biosciences (NASDAQ:EVFM) and Ayala Pharmaceuticals (NASDAQ:ADXS) Valuation and Earnings This table compares Ayala Pharmaceuticals and Evofem Biosciences"s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings…
businesswire.com OS Therapies Completes Acquisition of Advaxis Immunotherapies Clinical, Pre-clinical and IP Assets from Ayala Pharmaceuticals NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced…
businesswire.com OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostate Cancer Programs to Pipeline NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced it…
businesswire.com OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostrate Cancer Programs to Pipeline NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced it…
globenewswire.com Ayala Pharmaceuticals Files Form 15 to Voluntarily Deregister and Suspend its Reporting Obligations MONMOUTH JUNCTION, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that it filed a Form 15 with the Securities and…
globenewswire.com Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced…
globenewswire.com Ayala Pharmaceuticals Presents Updated AL102 Results from Phase 2 Clinical Trial in Desmoid Tumors at ESMO Congress 2023 AL102 1.2 mg once daily treatment achieved Overall Response Rate of 83% in the evaluable population AL102 1.2 mg once daily treatment resulted in 88% reduction in tumor volume and 85% reduction in…
globenewswire.com Ayala Pharmaceuticals Announces Closing of Merger with Biosight REHOVOT, Israel & MONMOUTH JUNCTION, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the closing of its merger…
globenewswire.com Ayala Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Corporate Update Successful End-of-Phase 2 meeting with FDA regarding AL102 for the treatment of desmoid tumors Enrollment in the Phase 3 segment of RINGSIDE trial evaluating AL102 continuing globally as planned…
globenewswire.com Ayala Pharmaceuticals Announces Abstracts on AL102 and AL101 Accepted for Presentation at ESMO Congress 2023 REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a publicly-traded clinical-stage oncology company, today announced that it…
globenewswire.com Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage oncology asset to Ayala's portfolio with data anticipated in the first half of 2024 REHOVOT and TEL AVIV,…
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023 
globenewswire.com Advaxis to Present Updated Clinical and Immunogenicity Data from Ongoing Phase 1/2 Trial of ADXS-503 in Metastatic Non-Small-Cell Lung Cancer (NSCLC) and Study Design of ADXS-504 Trial in Early Prostate Cancer at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting Overall response rate of 14% and disease control rate of 36% in Part B of ADXS-503 trial with durable clinical benefit as an add-on therapy to patients with prior disease progression on KEYTRUDA ®…
prnewswire.com OTC Markets Group Welcomes Advaxis, Inc. to OTCQX NEW YORK, Dec. 23, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Advaxis, Inc. (OTCQX: ADXS), a…
pennystocks.com 3 Hot Penny Stocks That Retail Traders Are Watching Right Now Why retail traders are watching these penny stocks right now The post 3 Hot Penny Stocks That Retail Traders Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information…
pennystocks.com Top Penny Stocks to Buy From TikTok? 3 That Investors Are Watching These penny stocks are popular on TikTok, are they on your watchlist? The post Top Penny Stocks to Buy From TikTok?
investorplace.com 6 of the Hottest Stocks to Pick Up for Less Than $1 These penny stocks are trading for under a dollar, but could change that in the coming months with their strong fundamentals. The post 6 of the Hottest Stocks to Pick Up for Less Than $1 appeared…
pennystocks.com Best Penny Stocks to Buy Next Month? 3 You Need to Know About Which penny stocks are on your November watchlist? The post Best Penny Stocks to Buy Next Month?
pennystocks.com Top Trending Penny Stocks to Watch Next Month With so many trending penny stocks to buy, which small caps are you watching? The post Top Trending Penny Stocks to Watch Next Month appeared first on Penny Stocks to Buy, Picks, News and Information…
pennystocks.com 3 Trending Penny Stocks For Your Small-Caps Watchlist Right Now These trending penny stocks could be worth adding to your October watchlist, here's why The post 3 Trending Penny Stocks For Your Small-Caps Watchlist Right Now appeared first on Penny Stocks to Buy,…
benzinga.com 72 Biggest Movers From Yesterday Gainers- benzinga.com 45 Stocks Moving In Monday's Mid-Day Session Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets.
- benzinga.com 21 Stocks Moving in Monday's Pre-Market Session Gainers Itamar Medical Ltd. (NASDAQ: ITMR) rose 43% to $29.52 in pre-market trading. Zoll Medical said it has signed an agreement to acquire Itamar Medical for $31 per ADS in cash.
benzinga.com 38 Stocks Moving In Thursday's Mid-Day Session Gainers Newegg Commerce Inc. (NASDAQ: NEGG) shares jumped 30% to $12.03.
benzinga.com 50 Biggest Movers From Yesterday Gainers MoSys, Inc. (NASDAQ: MOSY) shares jumped 44.1% to settle at $5.46 on Wednesday. Lianluo Smart Limited (NASDAQ: LLIT) gained 24.6% to settle at $9.22.- benzinga.com 35 Stocks Moving In Wednesday's Mid-Day Session Gainers Advaxis, Inc. (NASDAQ: ADXS) shares jumped 43.1% to $0.6943 after jumping over 14% on Tuesday. MoSys, Inc. (NASDAQ: MOSY) shares gained 32% to $5.00.
benzinga.com 30 Stocks Moving in Friday's Pre-Market Session Gainers- benzinga.com 101 Biggest Movers From Friday Gainers Atlantic American Corporation. (NASDAQ: AAME) shares surged 117.6% to close at $5.20 on Friday after surging over 5% on Thursday.
- benzinga.com 66 Stocks Moving In Friday's Mid-Day Session Gainers Atlantic American Corporation. (NASDAQ: AAME) shares jumped 279.5% to $9.07 after surging over 5% on Thursday.
- benzinga.com 40 Stocks Moving in Wednesday's Pre-Market Session Gainers Ocugen, Inc. (NASDAQ: OCGN) shares rose 75.1% to $1.41 in pre-market trading. Ocugen shares jumped around 174% on Tuesday after the company and Bharat Biotech announced plans to co-develop a…
- benzinga.com 80 Biggest Movers From Yesterday
benzinga.com 48 Stocks Moving In Monday's Mid-Day Session - benzinga.com Stocks That Hit 52-Week Lows On Wednesday
benzinga.com Stocks That Hit 52-Week Lows On Friday - benzinga.com Stocks That Set New 52-Week Lows Friday Morning
- benzinga.com List of Companies Reaching Yearly Lows Tuesday
- benzinga.com 48 Biggest Movers From Wednesday
- benzinga.com 60 Biggest Movers From Yesterday
- benzinga.com 44 Stocks Moving In Monday's Mid-Day Session
benzinga.com 52 Biggest Movers From Yesterday - benzinga.com 41 Stocks Moving In Monday's Mid-Day Session
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
- benzinga.com Stocks Which Set New 52-Week Low The Last Trading Session, Fri., Dec. 7, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018
- benzinga.com Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Lows Fri., Nov. 16, 2018